
-
Xi meets Putin in Moscow as Ukraine reports truce violations
-
Israel forces close UN schools in annexed east Jerusalem
-
Trump to announce 'trade deal' with UK
-
'Jumbo': the animated Indonesian film smashing records
-
Stocks rise on trade hopes, London boosted by reports of deal
-
Emirates airline group announces record $6.2 bn gross profit
-
Accused mushroom murderer sent children to movies before deadly meal
-
Nintendo forecasts 15 million Switch 2 sales in 2025-26
-
Australian Greens chief loses his own seat
-
Toyota cites tariffs as it forecasts 35% net profit drop
-
Wolf protection downgrade set for green light in EU
-
Global cult following keeps Le Creuset simmering
-
Austria's JJ makes operatic pop soar at Eurovision
-
Toyota cites tariffs as it forecasts 35% drop in 2025-26 net profit
-
Depoliticising Eurovision 'impossible', experts say
-
Trump official to unveil ambitious US air traffic control upgrade
-
India and Pakistan trade fire after deadly escalation
-
Knicks rally again to take 2-0 lead over Celtics, Thunder roar back
-
What the shell: scientists marvel as NZ snail lays egg from neck
-
Eurovision week's opening parade set to start the party
-
Trump to announce trade deal with UK on Thursday: US media
-
Dhoni says 'nothing to decide now' over retirement plans
-
A bitter return for Iraqis kicked out of Europe
-
Stocks rise further on growing trade deal hopes
-
Filipino pope could revive priestly vocations in Catholic bastion
-
NZ Rugby posts $11.6 mn loss, admits financial model 'not sustainable'
-
NZ Rugby posts $19.7mn loss, admits financial model 'not sustainable' financial model
-
All eyes on Sistine Chapel chimney as conclave enters day two
-
Digital voting breeds distrust among overseas Filipino workers
-
Bank of England set to cut rate amid Trump's tariffs
-
Trump tariff plan brings Hollywood's struggles into focus
-
'Dream turned nightmare' for Venezuelan migrant deported from US by Trump
-
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director’s Dealing
-
Agronomics Limited - Liberation Labs Announce Manufacturing Partnership
-
Malaysia Cybersecurity Center of Excellence Marks First Anniversary with New Partnerships, Scholarships and Expanded Programs
-
California leads lawsuit over Trump's EV charging funding change
-
Meta blocks access to Muslim news page in India
-
PSG are deserving Champions League finalists, says Luis Enrique
-
Bolsonaro leads rally at site of 2023 Brazil insurrection
-
Mexico City prepares to welcome millions for 2026 World Cup
-
Putin's order for three-day truce with Ukraine enters force
-
Defiant Arteta says Arsenal were best team in Champions League despite painful exit
-
US envoy Witkoff briefs UN Security Council on Gaza, other issues
-
Tens of thousands take part in Istanbul rally for jailed mayor
-
Pakistan warns will 'avenge' deaths from Indian strikes
-
US Fed pauses rate cuts again and warns of inflation, unemployment risks
-
New accuser testifies against Weinstein in New York retrial
-
Merz supports easing EU fiscal rules to boost defence spending
-
PSG finish off Arsenal to reach Champions League final
-
Ex-US police officers acquitted in beating death of Black motorist

Bayer sells pest control unit for $2.6 bn
German chemicals and pharmaceuticals giant Bayer said Thursday it has agreed to sell its pest control unit to British private equity firm Cinven for $2.6 billion (2.4 billion euros).
Bayer had announced last year its intention to offload its US-based unit, Environmental Science Professional.
"This divestment represents a very attractive purchase price and allows us to focus on our core agricultural business," said Rodrigo Santos, head of Bayer's Crop Science division.
Environmental Science Professional offers solutions to control pests, diseases and weeds in non-agricultural areas, including professional pest management, forestry and gardens.
The subsidiary has 800 employees and operates in more than 100 countries, with 600 million euros in turnover.
Bayer said it expects the transaction to be completed in the second half of this year, with proceeds to be used to reduce the group's net financial debt.
Bayer's debt has grown in recent years as it has been plagued by legal woes since it bought Monsanto in 2018.
It has faced a flood of cases in US courts by cancer patients who say the glyphosate chemical in the Roundup weedkiller caused them to fall ill. Bayer rejects the accusations.
C.Garcia--AMWN